Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oshri Machluf

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|May 28, 2026
Robust CATE estimation using novel ensemble methodsOshri Machluf, Tzviel Frostig, Tomer Milo, et al.
Cancers|May 25, 2024
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB StatusWalid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient OutcomesWalid Shalata, Alexander Gluzman, Sofia Man, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|May 28, 2026
Robust CATE estimation using novel ensemble methodsOshri Machluf, Tzviel Frostig, Tomer Milo, et al.
Cancers|May 25, 2024
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB StatusWalid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient OutcomesWalid Shalata, Alexander Gluzman, Sofia Man, et al.
Pageof 1